Please try another search
With prudent cost management and strong diversification strategies, Franklin Resources, Inc. (NYSE:BEN) appears a solid bet now. The company’s relatively strong distribution platform and...
What started off as another pleasing up market following a mild positive close on Tuesday turned into a blood-red market index in futures ahead of the bell this Valentine’s Day (Happy...
T. Rowe Price Group, Inc.’s (NASDAQ:TROW) board of directors recently approved a 23% hike in the company’s quarterly common stock dividend. The revised quarterly dividend now comes in at...
As the stock market begins to recover from the recent correction, investors may view this as an opportunity to invest on the cheap. Stocks may be cheaper now than they were last month, but that does...
Shares of Pepsico, Inc. (NASDAQ:PEP) increased 0.2% after posting fourth-quarter core earnings of $1.31 per share, beating the Zacks Consensus Estimate by a centThe Dun & Bradstreet...
Americans are expected to shell out more this Valentine’s Day thanks to solid adoption of smartphones and an upsurge in spending by millennials (25-34 age group). Per the National Retail...
Benchmarks closed in positive territory on Tuesday for three straight trading days after posting their worst weekly performance in two years. Despite registering gains on Tuesday, both the Dow and...
Welcome to Episode #119 of the Zacks Market Edge Podcast. Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds...
SINA Corporation’s (NASDAQ:SINA) fourth-quarter 2017 non-GAAP earnings of 79 cents per share surged 25.4% from the year-ago quarter and matched the Zacks Consensus Estimate.Net revenues grew...
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...
Merck & Co., Inc. (NYSE:MRK) announced that it is discontinuing another study evaluating verubecestat for the treatment of prodromal Alzheimer’s disease as its success was unlikely.APECS...
Eli Lilly and Company (NYSE:LLY) announced positive top-line data from a phase III label expansion study evaluating its psoriasis drug, Taltz (ixekizumab), in patients with ankylosing spondylitis...
Occidental Petroleum Corporation (NYSE:OXY) reported fourth-quarter 2017 earnings of 41 cents per share, beating the Zacks Consensus Estimate by a penny. In the year-ago quarter, the company had...
Molson Coors Brewing Company (NYSE:TAP) reported fourth-quarter 2017 results, wherein both the top and bottom line improved year over year and the latter also beat the Zacks Consensus Estimate....
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) were down around 4% on Tuesday, as another generic version of its blockbuster multiple sclerosis injection, Copaxone was launched earlier...